Gain Therapeutics Inc (NASDAQ:GANX)’s traded shares stood at 0.36 million during the last session, with the company’s beta value hitting 0.14. At the close of
In the last trading session, 0.27 million shares of the Gain Therapeutics Inc (NASDAQ:GANX) were traded, and its beta was 0.15. Most recently the company’s
During the last session, Gain Therapeutics Inc (NASDAQ:GANX)’s traded shares were 0.36 million, with the beta value of the company hitting 0.14. At the end
Gain Therapeutics Inc (NASDAQ:GANX)’s traded shares stood at 0.56 million during the last session, with the company’s beta value hitting 0.23. At the close of
In the last trading session, 0.11 million Gain Therapeutics Inc (NASDAQ:GANX) shares changed hands as the company’s beta touched 0.24. With the company’s per share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
